Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Commercial Officer

Chief Scientific Officer

Chief Accounting Officer

President and CEO

Chief Technology Officer

Chief Legal Officer

SVP, Chief of Staff

Chief Financial Officer

Chief People Officer

Chief Operating Officer

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It also provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, or metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic Test, a RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic Test, a RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor, a solution for precision oncology; and Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus. Further, it provides Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; and GeneSight Psychotropic Mental Health Medication Test, a DNA genotyping test to aid psychotropic drug selection for patients suffering from depression, anxiety, ADHD, and other mental health conditions. Myriad Genetics, Inc. has a strategic collaboration with Illumina, Inc. and Intermountain Precision Genomics. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops genetic tests in the United States and internationally.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-14	Premium	sold (taxes)	Premium	Premium	Premium	Chief Commercial Officer
2024-04-14	Premium	sold (taxes)	Premium	Premium	Premium	Chief Scientific Officer
2024-04-06	Premium	sold (taxes)	Premium	Premium	Premium	Chief Accounting Officer
2024-03-25	Premium	sold (taxes)	Premium	Premium	Premium	Chief Accounting Officer
2024-03-24	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2024-03-24	Premium	sold (taxes)	Premium	Premium	Premium	Chief Technology Officer
2024-03-24	Premium	sold (taxes)	Premium	Premium	Premium	Chief Scientific Officer
2024-03-24	Premium	sold (taxes)	Premium	Premium	Premium	Chief Commercial Officer
2024-03-24	Premium	sold (taxes)	Premium	Premium	Premium	Chief Accounting Officer
2024-03-22	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2024-03-22	Premium	sold (taxes)	Premium	Premium	Premium	Chief Accounting Officer
2024-03-22	Premium	sold (taxes)	Premium	Premium	Premium	Chief Legal Officer
2024-03-22	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Chief of Staff
2024-03-22	Premium	sold (taxes)	Premium	Premium	Premium	Chief Scientific Officer
2024-03-22	Premium	sold (taxes)	Premium	Premium	Premium	Chief Technology Officer
2024-03-22	Premium	sold (taxes)	Premium	Premium	Premium	Chief Commercial Officer
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Legal Officer
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Scientific Officer
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Chief of Staff
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Technology Officer
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Commercial Officer
2024-03-14	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-03-14	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-03-14	Premium	acquired	Premium	Premium	Premium	Chief People Officer

MYGN - Myriad Genetics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for MYGN